Brief: I'rom Group unit concludes iPS cell generation technology licensing agreement with UK-based Elpis Biomed

I'rom Co

22/08/2018 07:47

Aug 22(Reuters) - I'rom Group Co Ltd  2372.T  
    
    * Says its wholly owned unit ID Pharma concluded an iPS cell
generation technology licensing agreement with UK-based Elpis
Biomed Limited
    * Under this agreement, Elpis Biomed Limited will pay
up-front
payment and royalties to ID Pharma 

    
    
    Source text in Japanese:https://goo.gl/dVjWEX
    Further company coverage: 2372.T 

 (Beijing Headline News)
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724;
Reuters Messaging: huafang.zhang.reuters.com@reuters.net))